FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18252511000001100: Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62530401000001113 Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62530501000001112 Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Is a Felodipine 10mg modified-release tablets true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Is a Felodipine 10mg m/r tablet false Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has active ingredient Felodipine true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has specific active ingredient Felodipine true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Is a Vascalpha true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Is a Felodipine 10mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Vascalpha 10mg modified-release tablets (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start